Dr. Martin Hoenigl, Professor of Translational Mycology at the Medical University of Graz, is an internationally recognized expert in clinical mycology with 300+ publications and multiple global awards.

Qualification :

• MD in Human Medicine, Medical University of Graz (2008).
• Habilitation in Internal Medicine (2012) on invasive fungal infections.
• Postdoctoral training and fellowships in Infectious Diseases, Pulmonology, and Translational Mycology at UC San Diego and Graz.

Experiences :

• Tenured Professor for Translational Mycology, Medical University of Graz (since 2021).
• Associate Adjunct Professor of Medicine, UC San Diego (2021–2022).
• Lecturer and Fellowship training at Medical University of Graz (2009–2018).
• Assistant Research Scientist and Postdoctoral Fellow at UC San Diego (2014–2018).
• Extensive international clinical clerkships in Canada, Vietnam, and Germany.
• Leadership roles in European Confederation of Medical Mycology (President 2017–2023, now Clinical Study Director).
• Associate Editor for multiple journals (Mycoses, OFID, Mycopathologia).

Current Role :

• Tenured Professor of Translational Mycology at the Division of Infectious Diseases, Medical University of Graz, Austria.
• Clinical Study Director of the European Confederation of Medical Mycology (ECMM).
• Editorial positions with leading infectious diseases journals.

Specialization & Expertise :

• Clinical Mycology, Virology, and Infectious Diseases
• Invasive fungal infections, infections in hematology, translational mycology
• Extensive teaching, editorial, and leadership roles in international mycology organizations

Milestones & Awards :

• Researcher of the Year, Medical University of Graz (2011)
• ICAAC Infectious Disease Fellow Grant, ASM (2010)
• Two-time George McCracken Infectious Disease Fellow Award, ASM (2009, 2013)
• Research Promotion Award, German Speaking Mycological Society (2014)
• Ira F. Salkin Award for Publication of the Year in Medical Mycology (2018)
• ID Week Diagnostic Award (2018)

Research & Articles :

• Over 300 PubMed-listed publications (2008–present)
• High-impact papers as leading author in Lancet Infectious Diseases, Lancet Microbe, Journal of Infection, Nature Microbiology, Clinical Infectious Diseases, etc.
• Supervised 13 diploma theses, 7 doctoral theses, and 11 postdoctoral fellows